196 Results

People

  1. De Angelis
    De Angelis
  2. Kelsen
    Kelsen
  3. O'Reilly
    O'Reilly
  4. Hudis
    Hudis
  5. Amar
    Amar
  6. Ilson
    Ilson
  7. Kelly
    Kelly
  8. Aghajanian
    Aghajanian
  9. Shah
    Shah
  10. Saltz
    Saltz

Groups

  1. Department of Medicine (108)
  2. Solid Tumor Oncology Division (82)
  3. Surgery (37)
  4. Survivorship Research (32)
  5. Gastrointestinal Oncology Service (30)
  6. Hematologic Malignancies, Division of (29)
  7. Epidemiology and Biostatistics (23)
  8. Center for Hematologic Malignancies (21)
  9. Center for Pancreatic Cancer Research (19)
  10. Genitourinary Oncology Service (19)
  1. "thromboembolism"
Formats
  1. Journal Article (181)
  2. Review (9)
  3. Editorial (2)
  4. Book Section (1)
  5. Correspondence (1)
  6. Guidelines (1)
  7. Meeting Abstract (1)
Groups
  1. Department of Medicine (108)
  2. Solid Tumor Oncology Division (82)
  3. Surgery (37)
  4. Survivorship Research (32)
  5. Gastrointestinal Oncology Service (30)
  6. Hematologic Malignancies, Division of (29)

More Groups

People
  1. David Kelsen (10)
  2. Eileen O'Reilly (10)
  3. Lisa De Angelis (10)
  4. Clifford Hudis (9)
  5. David Amar (8)
  6. David Ilson (8)

More People

Years
  1. 2025 (3)
  2. 2024 (12)
  3. 2023 (7)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (2)

More Years

Publications
  1. Cancer (12)
  2. Gynecologic Oncology (12)
  3. Journal of Clinical Oncology (10)
  4. Journal of the National Comprehensive Cancer Network (10)
  5. European Urology (5)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (41)
  2. Wiley Blackwell (22)
  3. Elsevier Science, Inc. (20)
  4. Springer (15)
  5. Oxford University Press (13)
  6. American Society of Clinical Oncology (10)

More Publishers

Results (196)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)
    Journal Article

    Patel, J. N.; Jiang, C.; Hertz, D. L.; Mulkey, F. A.; Owzar, K.; Halabi, S.; Ratain, M. J.; Friedman, P. N.; Small, E. J.; Carducci, M. A.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
    Journal Article

    Sikov, W. M.; Berry, D. A.; Perou, C. M.; Singh, B.; Cirrincione, C. T.; Tolaney, S. M.; Kuzma, C. S.; Pluard, T. J.; Somlo, G.; Port, E. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer
    Journal Article

    Zivanovic, O.; Abramian, A.; Kullmann, M.; Fuhrmann, C.; Coch, C.; Hoeller, T.; Ruehs, H.; Keyver-Paik, M. D.; Rudlowski, C.; Weber, S.; more...
    International Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Current role of anti-angiogenic strategies for glioblastoma
    Journal Article

    Thomas, A. A.; Omuro, A.
    Current Treatment Options in Oncology (2014)

    Fulltext@MSK | Save
  • The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
    Journal Article

    Bambury, R. M.; Morris, P. G.
    Expert Review of Anticancer Therapy (2014)

    Fulltext@MSK | Save
  • A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
    Journal Article

    Lee, J. K.; Capanu, M.; O'Reilly, E. M.; Ma, J.; Chou, J. F.; Shia, J.; Katz, S. S.; Gansukh, B.; Reidy-Lagunes, D.; Segal, N. H.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: An early glimpse into a challenging initiative
    Journal Article

    Cohn, D. E.; Leitao, M.; Levenback, C.; Berkowitz, R.; Roman, L.; Lucci, J.; Kim, S.; Lancaster, J.; Odunsi, K.; Wakabayashi, M.; more...
    Gynecologic Oncology (2013)

    Fulltext@MSK | Save
  • Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications
    Journal Article

    DeSancho, M. T.; Pastores, S. M.
    Evidence-Based Medicine (2013)

    Fulltext@MSK | Save
  • Thromboembolic events following surgery for prostate cancer
    Journal Article

    Van Hemelrijck, M.; Garmo, H.; Holmberg, L.; Bill-Axelson, A.; Carlsson, S.; Akre, O.; Stattin, P.; Adolfsson, J.
    European Urology (2013)

    Fulltext@MSK | Save
  • Exocrine pancreas cancer and thromboembolic events: A systematic literature review
    Journal Article

    Epstein, A. S.; O'Reilly, E. M.
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save